A woman holding her pill box

Why breast cancer survivors don’t take their meds, and what can be done about it

Aug. 28, 2023

Hormone-blocking drugs can be life-saving for breast cancer survivors, reducing risk of recurrence by as much as 50%. Yet many patients stop taking them early or don’t take them as directed. A new CU Boulder study explores why, and what can be done about it.

Lead author Molly McDermott tagging a swallow

Building a nest in The Giving Tree

Aug. 22, 2023

Even with increased physical costs, female barn swallows prioritize the needs of their offspring over their own health. Though songbirds are the focus of the new study, it might pertain to many species—humans included—and the price of parenthood.

Older person holding a cane

Bad news: There’s no magic cure for aging

Aug. 4, 2023

CU Boulder researcher Jesse Kurland shows in a new study that aging is a complex process affecting genetic networks, and altering one gene won’t stop it.

Two people at a point-of-sale system. (Clay Banks/Unsplash)

‘The pill’ will soon be available over the counter. The impacts could be sweeping

July 13, 2023

Federal regulators approved the first over-the-counter oral contraceptive. CU Boulder’s Amanda Stevenson says the impacts could be sweeping. But she cautions that real threats to contraceptive access in the U.S. still exist.

Woman works at large piece of scientific equipment

Weeks later, potentially harmful chemicals lingered in homes affected by Marshall Fire

July 6, 2023

In the wake of the devastating Marshall Fire, a team of chemists and engineers from CU Boulder undertook a first-of-its-kind study to explore homes that survived the blaze. Their results reveal the potential health hazards that wildfires can leave behind in buildings.

Maciej Walczak and his lab group

Chemist to study molecular inner workings of Alzheimer’s disease

July 6, 2023

Maciej Walczak, CU Boulder associate professor of chemistry, won a $2 million NIH grant to investigate how certain sugars modify a brain protein associated with neurodegeneration.

Breast tumor seen under a microscope

When it comes to treating resistant breast cancer, 2 drugs may be better than 1

June 15, 2023

New research shows that cancer cells can adapt in as little as one to two hours to new drugs called CDK2 inhibitors. The good news: Adding a second, widely available drug disables this workaround, squelching tumor growth.

The HIV virus, a retrovirus, under the microscope

Remnants of ancient virus may fuel ALS in people

June 6, 2023

An ancient, virus-like protein best known for its essential role in placental development may, when over-expressed, fuel ALS—aka Lou Gehrig's disease—and other neurodegenerative diseases, according to new research. The discovery opens the door to a new class of potential treatments.

Jennifer Doudna stands on stage at a podium

Forum on gene editing draws hundreds, some with tough questions

May 25, 2023

A revolutionary technique for editing genomes, called CRISPR-Cas9, has already helped cure sickle cell disease in dozens of people. But it also raises ethical concerns, which a panel of preeminent scientists grappled with at an event on the CU Boulder campus.

Cigarette burning

Does the sweet seduction of flavored tobacco make quitting harder?

May 4, 2023

A study led by a CU Boulder researcher finds that flavored tobacco products reduce the likelihood of cessation later, but researchers say more investigation is needed.